Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | 0.00% | -11.11% | -42.86% |
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.1M 8.35M |
---|---|---|---|---|---|
Net income 2022 | -5M -6.84M | Net income 2023 | -2M -2.74M | EV / Sales 2022 | - |
Net Debt 2022 | 3.99M 5.46M | Net Debt 2023 | 4.17M 5.7M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.41
x | P/E ratio 2023 |
-2.31
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.85% |
Latest transcript on Hemostemix Inc.
1 week | -11.11% | ||
1 month | -38.46% | ||
3 months | -55.56% | ||
6 months | -46.67% | ||
Current year | -42.86% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Smeenk
FOU | Founder | - | 05-12-31 |
Christina Wu
DFI | Director of Finance/CFO | - | 20-03-04 |
Peter Pavlin
COO | Chief Operating Officer | - | 22-05-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Lacey
CHM | Chairman | 67 | 20-03-10 |
Ronnie Hershmann
BRD | Director/Board Member | - | 20-02-08 |
Thomas Smeenk
FOU | Founder | - | 05-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.04 | 0.00% | 91,000 |
24-05-02 | 0.04 | +14.29% | 43,000 |
24-05-01 | 0.035 | -12.50% | 97,777 |
24-04-30 | 0.04 | 0.00% | 57,000 |
24-04-29 | 0.04 | -11.11% | 5,000 |
Delayed Quote Toronto S.E., May 03, 2024 at 01:57 pm EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-42.86% | 2.55M | |
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+6.79% | 14.16B | |
+38.61% | 12.63B |
- Stock Market
- Equities
- HEM Stock